(-0.04%) 5 431.60 points
(-0.15%) 38 589 points
(0.12%) 17 689 points
(-0.17%) $78.49
(-2.47%) $2.89
(1.31%) $2 348.40
(1.91%) $29.62
(0.90%) $963.20
(0.31%) $0.934
(0.26%) $10.67
(0.59%) $0.788
(1.77%) $89.43
2 days till quarter result
(bmo 2024-06-18)
Expected move: +/- 6.31%
-0.91% $ 5.45
Live Chart Being Loaded With Signals
Pluri Inc., a biotechnology company, focuses on the development of placenta-based cell therapy product candidates for the treatment of multiple inflammatory, muscle injuries, and hematologic conditions...
Stats | |
---|---|
Dzisiejszy wolumen | 1 544 |
Średni wolumen | 26 296 |
Kapitalizacja rynkowa | 29.37M |
EPS | $-1.010 ( Q3 | 2024-03-31 ) |
Następna data zysków | ( $0 ) 2024-06-18 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
-1.320 (Sector) 42.63 (Industry) 24.32 |
ATR14 | $0 (0.00%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-01-23 | Franco-yehuda Chen | Buy | 355 000 | Common Stock |
2024-01-23 | Aberman Zami | Buy | 44 100 | Common Stock |
2024-01-23 | Birger Pinhas Doron | Buy | 39 900 | Common Stock |
2024-01-23 | Shemesh-rasmussen Maital | Buy | 38 150 | Common Stock |
2024-01-23 | Yanay Yaky | Buy | 700 000 | Common Stock |
INSIDER POWER |
---|
99.92 |
Last 95 transactions |
Buy: 8 548 074 | Sell: 1 004 814 |
Pluri Inc. Korelacja
10 Najbardziej pozytywne korelacje |
---|
10 Najbardziej negatywne korelacje |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Pluri Inc. Finanse
Annual | 2023 |
Przychody: | $287 000 |
Zysk brutto: | $278 000 (96.86 %) |
EPS: | $-6.18 |
FY | 2023 |
Przychody: | $287 000 |
Zysk brutto: | $278 000 (96.86 %) |
EPS: | $-6.18 |
FY | 2022 |
Przychody: | $234 000 |
Zysk brutto: | $-41.36M (-17 674.79 %) |
EPS: | $-1.270 |
FY | 2021 |
Przychody: | $0.00 |
Zysk brutto: | $0.00 (0.00 %) |
EPS: | $-1.770 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Pluri Inc.
Pluri Inc., a biotechnology company, focuses on the development of placenta-based cell therapy product candidates for the treatment of multiple inflammatory, muscle injuries, and hematologic conditions. The company develops placental expanded (PLX) based cell therapy products, including PLX-PAD that is in Phase III clinical trials for the muscle recovery after surgery for hip fracture; in Phase II clinical trails for the treatment of acute respiratory distress syndrome associated with COVID-19; and in Phase I/II clinical trial for treatment of steroid-refractory graft versus host disease. It also develops PLX-R18 for incomplete hematopoietic recovery following hematopoietic cell transplantation, as well as a solution for the treatment of acute radiation syndrome. The company was formerly known as Pluristem Therapeutics Inc. and changed its name to Pluri Inc. in July 2022. Pluri Inc. was incorporated in 2001 and is based in Haifa, Israel.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej